-
1.发明申请2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators 失效2-氨基羰基取代的哌嗪或二氮杂环化合物作为凋亡蛋白抑制剂（Iap）调节剂公开(公告)号：US20080207630A1
公开(公告)日：2008-08-28
申请号：US11911418
申请日：2006-04-13
申请人： Robert Eckl , Roswitha Taube , Michael Almstetter , Michael Thormann , Andreas Treml , Christopher Straub , Zhuoliang Chen
发明人： Robert Eckl , Roswitha Taube , Michael Almstetter , Michael Thormann , Andreas Treml , Christopher Straub , Zhuoliang Chen
IPC分类号： A61K31/496 , C07D241/04 , A61P35/04
CPC分类号： C07D241/04 , C07D295/185 , C07D401/04 , C07D403/06 , C07K5/06052 , C07K5/0806 , C07K7/06
摘要： The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates or pharmaceutically acceptable formulations thereof. These compounds may be used to modulate cellular proliferation and to prevent and/or treat proliferative diseases.
摘要翻译： 本发明涉及式（I）化合物或其药学上可接受的盐，溶剂合物，水合物或其药学上可接受的制剂。 这些化合物可用于调节细胞增殖并预防和/或治疗增殖性疾病。
-
2.发明授权2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators 失效2-氨基羰基取代的哌嗪或二氮杂环化合物作为凋亡蛋白抑制剂（lap）调节剂公开(公告)号：US07932255B2
公开(公告)日：2011-04-26
申请号：US11911418
申请日：2006-04-13
申请人： Robert Eckl , Roswitha Taube , Michael Almstetter , Michael Thormann , Andreas Treml , Christopher Straub , Zhouliang Chen
发明人： Robert Eckl , Roswitha Taube , Michael Almstetter , Michael Thormann , Andreas Treml , Christopher Straub , Zhouliang Chen
IPC分类号： A61K31/4965 , A61K31/00 , C07D241/04 , C07D295/00 , C07D243/08 , A01N43/00
CPC分类号： C07D241/04 , C07D295/185 , C07D401/04 , C07D403/06 , C07K5/06052 , C07K5/0806 , C07K7/06
摘要： The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates or pharmaceutically acceptable formulations thereof. These compounds may be used to modulate cellular proliferation and to prevent and/or treat proliferative diseases.
摘要翻译： 本发明涉及式（I）化合物或其药学上可接受的盐，溶剂合物，水合物或其药学上可接受的制剂。 这些化合物可用于调节细胞增殖并预防和/或治疗增殖性疾病。
-
公开(公告)号：US09802937B2
公开(公告)日：2017-10-31
申请号：US13506510
申请日：2012-04-23
IPC分类号： C07D487/04 , A61K31/519 , A61P29/00 , A61P11/06 , A61P37/08 , A61P27/02 , A61P17/04 , A61P37/06 , A61P35/02 , A61P35/04 , A61P35/00 , C07D519/00
CPC分类号： C07D487/04 , C07D519/00
摘要： The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer's disease, parkinson's disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.
-
4.发明授权RecA inhibitors with antibiotic activity, compositions and methods of use 有权具有抗生素活性的RecA抑制剂，组合物和使用方法公开(公告)号：US09155792B2
公开(公告)日：2015-10-13
申请号：US12279243
申请日：2007-02-13
申请人： Guillaume Cottarel , Jamey Wierzbowski , Kollol Pal , Michael Kohanski , Daniel Dwyer , James Collins , Michael Almstetter , Michael Thormann , Andreas Treml
发明人： Guillaume Cottarel , Jamey Wierzbowski , Kollol Pal , Michael Kohanski , Daniel Dwyer , James Collins , Michael Almstetter , Michael Thormann , Andreas Treml
CPC分类号： A61K45/06 , A61K38/12 , C12Q1/18 , G01N33/5023 , A61K2300/00
摘要： The present invention is directed to the use of RecA inhibitors as antibiotic agents, and provides RecA inhibitors useful in treating infections. Also provided are various compositions and methods associated with RecA inhibition.
摘要翻译： 本发明涉及使用RecA抑制剂作为抗生素，并提供可用于治疗感染的RecA抑制剂。 还提供了与RecA抑制有关的各种组合物和方法。
-
5.发明授权Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions 有权使用isoQC抑制剂治疗和预防炎性疾病或病症公开(公告)号：US08889709B2
公开(公告)日：2014-11-18
申请号：US12554584
申请日：2009-09-04
申请人： Hans-Ulrich Demuth , Stephan Schilling , Michael Wermann , Holger Cynis , Astrid Kehlen , Daniel Friedrich , Torsten Hoffmann , Kathrin Gans , Jens-Ulrich Rahfeld , Ulrich Heiser , Michael Almstetter , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Thormann , Andreas Treml
发明人： Hans-Ulrich Demuth , Stephan Schilling , Michael Wermann , Holger Cynis , Astrid Kehlen , Daniel Friedrich , Torsten Hoffmann , Kathrin Gans , Jens-Ulrich Rahfeld , Ulrich Heiser , Michael Almstetter , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Thormann , Andreas Treml
IPC分类号： A01N43/42 , C12N9/00 , C12N9/10 , C12N1/20 , C12N15/00 , C07H21/04 , C07D417/12 , C07D405/12 , C07D233/61 , C07D409/12 , C07D403/12 , C07D413/12 , C07D403/06 , C07D401/12 , C07D233/54 , C07D235/06
CPC分类号： C07D233/54 , C07D233/61 , C07D235/06 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C12N9/104
摘要： The present invention relates in general to an inhibitor of a glutaminyl peptide cyclotransferase-like protein (QPCTL), and the use thereof for the treatment and/or prevention of an inflammatory disease or disorder selected from the group consisting of (a) chronic and acute inflammations, e.g. rheumatoid arthritis, atherosclerosis, restenosis, pancreatitis; (b) other inflammatory diseases, e.g. neuropathic pain, graft rejection/graft failure/graft vasculopathy, HIV infections/AIDS, gestosis, tuberous sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinizing polyradiculoneuropathy and multiple sclerosis; (c) neuroinflammation; and (d) neurodegenerative diseases, e.g. mild cognitive impairment (MCI), Alzheimer's disease, neurodegeneration in Down Syndrome, Familial British Dementia, and Familial Danish Dementia, which may result from neuroinflammation.
摘要翻译： 本发明一般涉及谷氨酰胺肽环转移酶样蛋白（QPCTL）的抑制剂及其用于治疗和/或预防炎性疾病或病症的用途，所述炎性疾病或病症选自（a）慢性和急性 炎症，例如 类风湿关节炎，动脉粥样硬化，再狭窄，胰腺炎; （b）其他炎性疾病，例如 艾滋病，睾丸炎，结节性硬化症，吉兰巴利综合征，慢性炎性脱髓鞘性多发性神经系统疾病和多发性硬化; （c）神经炎症; 和（d）神经变性疾病，例如 轻度认知障碍（MCI），阿尔茨海默氏症，唐氏综合征神经变性，家族性英国痴呆和家族性丹麦痴呆，可能由神经炎症引起。
-
公开(公告)号：US20100119475A1
公开(公告)日：2010-05-13
申请号：US12554611
申请日：2009-09-04
申请人： Ulrich Heiser , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Almstetter , Michael Thormann , Andreas Treml , Hans-Ulrich Demuth , Torsten Hoffman
发明人： Ulrich Heiser , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Almstetter , Michael Thormann , Andreas Treml , Hans-Ulrich Demuth , Torsten Hoffman
IPC分类号： A61K31/4184 , C07D417/14 , C07D403/10 , C07D405/14 , C07D471/04 , A61K31/433 , A61K31/4439 , A61K39/395 , A61K38/20 , A61K38/21 , A61P35/00 , A61P3/00 , A61P25/00
CPC分类号： C07D403/04 , C07D403/06 , C07D405/14 , C07D417/04 , C07D417/14 , C07D471/04
摘要： Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
摘要翻译： 通式（I）的化合物：其中R1，R2，R3，R4，X和Y如本文所定义，是谷氨酰胺酰环化酶的抑制剂，因此可用于治疗可通过调节谷氨酰胺酰环化酶活性治疗的病症。
-
公开(公告)号：US20070244177A1
公开(公告)日：2007-10-18
申请号：US11734369
申请日：2007-04-12
IPC分类号： A61K31/416 , A61K31/4152 , C07D403/02 , C07D231/12
CPC分类号： C07D409/06 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06
摘要： There is dislosed herein compounds of formula (I), wherein:R1, R2, R3, R4 and R5 are defined throughout the description and the claims. The compounds of formula (I) are useful for the treatment of neurological diseases and neurodegenerative diseases, e.g. anxiety, depression, Alzheimer's disease etc.
摘要翻译： 在本文中，式（I）的化合物是非离子的，其中：R 1，R 2，R 3，R 4， 在整个说明书和权利要求书中限定了SUP＆gt;和R＆lt; 5＆gt;。 式（I）化合物可用于治疗神经疾病和神经变性疾病，例如， 焦虑，抑郁，阿尔茨海默病等
-
公开(公告)号：US08962860B2
公开(公告)日：2015-02-24
申请号：US12554611
申请日：2009-09-04
申请人： Ulrich Heiser , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Almstetter , Michael Thormann , Andreas Treml , Hans-Ulrich Demuth , Torsten Hoffman
发明人： Ulrich Heiser , Robert Sommer , Ulf-Torsten Gaertner , Antje Hamann , Michael Almstetter , Michael Thormann , Andreas Treml , Hans-Ulrich Demuth , Torsten Hoffman
IPC分类号： C07D403/04 , C07D403/06 , C07D417/04 , C07D471/04 , C07D405/14 , C07D417/14
CPC分类号： C07D403/04 , C07D403/06 , C07D405/14 , C07D417/04 , C07D417/14 , C07D471/04
摘要： Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
摘要翻译： 通式（I）的化合物：其中R1，R2，R3，R4，X和Y如本文所定义，是谷氨酰胺酰环化酶的抑制剂，因此可用于治疗可通过调节谷氨酰胺酰环化酶活性治疗的病症。
-
公开(公告)号：US20120329785A1
公开(公告)日：2012-12-27
申请号：US13506509
申请日：2012-04-23
IPC分类号： C07D471/04 , C07D401/14 , A61K31/496 , A61K31/5513 , A61P27/02 , A61K31/5377 , A61P29/00 , A61P37/06 , A61P37/08 , A61K31/437 , C07D413/14
CPC分类号： C07D471/04
摘要： The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases.
摘要翻译： 本发明涉及能够抑制一种或多种激酶，特别是SYK（脾脏酪氨酸激酶），LRRK2（富含亮氨酸重复激酶2）和/或MYLK（肌球蛋白轻链激酶）的新型的式（I）化合物或 其突变体。 该化合物可用于治疗各种疾病。
-
公开(公告)号：US20100234397A1
公开(公告)日：2010-09-16
申请号：US12750930
申请日：2010-03-31
IPC分类号： A61K31/497 , A61K31/4164 , A61K31/4439 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/08 , A61P25/18 , A61P29/00 , A61P37/00 , A61P35/00 , A61P37/06
CPC分类号： C07D409/06 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06
摘要： There is disclosed herein methods for using compounds of formula (I), wherein: R1, R2, R3, R4 and R5 are defined throughout the description and the claims. The compounds of formula (I) are useful for the treatment of neurological diseases and neurodegenerative diseases, e.g. anxiety, depression, Alzheimer's disease etc.
摘要翻译： 本文公开了使用式（I）化合物的方法，其中：在整个说明书和权利要求书中限定了R1，R2，R3，R4和R5。 式（I）化合物可用于治疗神经疾病和神经变性疾病，例如， 焦虑，抑郁，阿尔茨海默病等
-
-
-
-
-
-
-
-
-
搜索结果
19 条记录 (耗时 0.042 秒)
